Diagnostic and prognostic role of <scp>SCCA</scp>‐<scp>IgM</scp> serum levels in hepatocellular carcinoma (<scp>HCC</scp>)

Abstract

SCCA-IgM is a sensitive marker of HCC in patients with cirrhosis even though lacking in specificity. The determination of the levels of the marker in HCC patients is highly efficient in predicting the patients' prognosis, identifying those with long overall and progression-free survival and the responders and should be introduced in the clinical practice.